Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 21 clinical trials
Neoadjuvant T-VEC in High Risk Early Melanoma

The investigators plan for thorough exploratory analysis of genetic and microenvironmental changes to identify actionable targets in incomplete as well as evaluation of changes in sentinel burden and subsequent rates of locoregional disease control, recurrence-free survival and overall survival in long term follow up. The investigators predict that histologic clearance …

metastasis
hysterectomy
tubal ligation
hepatitis
cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions

Prospective phase I study to evaluate the maximum tolerated dose (MTD) of SBRT for thoracic re-irradiation. Dose limiting toxicity will be pneumonitis G3. The potential advantage of the dose escalation planned in this study is the delivery of an ablative dose to radically treat patients with inoperable local relapse, without …

metastasis
pulmonary metastasis
non-small cell lung cancer
stereotactic body radiation therapy
small cell lung cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

The blood brain barrier (BBB) prevents some drugs from successfully reaching the target source. Convection-Enhanced Delivery (CED) is a method of direct infusion of drugs under controlled pressure to the tumor that may reduce systemic side effects of drugs in the patient. The purpose of this Phase I study is …

pediatric
diffuse intrinsic pontine glioma
seizures
coagulation disorder
karnofsky performance status
  • 0 views
  • 16 Feb, 2024
  • 1 location
Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma

The investigators propose a phase II randomized-controlled study on using durvalumab in combination with induction chemotherapy followed by concurrent chemoradiation and adjuvant durvalumab, compared to induction chemotherapy followed by concurrent chemoradiation for previously untreated locoregionally advanced stage III to IVA NPC. In parallel, the investigators will also perform collateral tumor …

hormone levels
cisplatin
luteinizing hormone
intra-articular injection
irreversible toxicity
  • 0 views
  • 05 Aug, 2020
Database ITANET - ENETS Registry

This is a prospective observational study with the aim to create an Italian database for the collection of data on diagnostic approach, therapy and follow up of patients affected by GEP-NET (gastro-enteric-pancreatic neuroendocrine tumours) and to include these data into a multi-national European registry database, adhering to the ENETS (european …

  • 0 views
  • 16 Feb, 2024
  • 8 locations
Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases

To observe the quality of life (QOL) and to report on toxicity and outcome parameters after the (repeated) use of local ablative therapy (LAT) i.e. stereotactic radiotherapy (SRT) for patients with multiple (4-10) brain metastases

metastasis
dental caries
MET
brain metastases
small cell lung cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
Skin Toxicity by Oncological Therapies (SKINTOX)

This is a multicenter, retrospective and prospective observational study. The project involves the collection of clinical data of patients treated with oncological therapies, to evaluate skin toxicities related to oncological treatment.

  • 0 views
  • 15 Nov, 2021
  • 20 locations
Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer

According to general medical guidelines, adjuvant chemotherapy is used after curative resection of high-risk stage II or III primary colon cancer. However, there exist limitations using clinical trial data acquired from highly selected subjects in a controlled environment. For example, patients aged over 70 years old were in many cases …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients

Current guidelines lack definitive evidences about the relative benefits of locoregional surgery for the primary tumor in de novo stage IV breast cancer. The aim of this study (SYSBTC-001) was to investigate the role of locoregional surgery for primary tumor in de novo stage IV breast cancer.

metastasis
stage iv breast cancer
breast cancer
invasive breast cancer
cancer
  • 0 views
  • 16 Feb, 2024
  • 3 locations
The Use of Indocyanine Green as a Diagnostic Adjunct for Pediatric Solid Malignancies

Use of indocyanine green will augment the accuracy of identification and resection of both primary solid malignancies as well as their pulmonary metastases, where applicable We will conduct a prospective feasibility study of pediatric patients with solid malignancies with or without lung metastatases who present at the time of initial …

metastasis
pulmonary metastasis
metastatic malignancy
ct scan
cancer
  • 0 views
  • 05 Aug, 2020